Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06207994

PRICO: OPTI Target Range

Evaluation of the Impact of a Narrower SpO2 Target Range on Performance of an Automatic FiO2 Control System: a Randomized Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Czech Technical University in Prague · Academic / Other
Sex
All
Age
2 Weeks
Healthy volunteers
Not accepted

Summary

The aim of the study is to determine if a narrower SpO2 Target Range setting automated control of FiO2 (A-FiO2) is more effective than a wider SpO2 Target Range

Detailed description

A-FiO2 systems have consistently proven to be more effective than manual control. Because it is more precise than manual control, studies of some A-FiO2 systems found small differences in the set target range (shift in the median and width) can optimize the relative performance. Similar studies of the A-FiO2 system (PRICO) used in the investigator's NICU have not been conducted. The standard of practice in the investigator's NICU is to use 4 different target ranges to balance the risk of hypoxia and hyperoxia based on the gestational age vulnerabilities. Based on the studies of other A-FiO2 systems the investigators believe a slightly narrower width target range would be more effective. Therefore, a small systematic study is needed to determine the optimal set target range to achieve the therapeutic goal.

Conditions

Interventions

TypeNameDescription
DEVICENarrow TRThe width of the PRICO SpO2 TR is set to 3% SpO2.
DEVICEShifted TRThe lower and the upper limits of the PRICO SpO2 TR are increased by 1% SpO2.

Timeline

Start date
2024-02-20
Primary completion
2025-09-01
Completion
2025-09-01
First posted
2024-01-17
Last updated
2025-03-25

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT06207994. Inclusion in this directory is not an endorsement.